BioArctic AB (publ) (BIOA-B.ST)

SEK 170.0

(-0.93%)

Total Debt Summary of BioArctic AB (publ)

  • BioArctic AB (publ)'s latest annual total debt in 2023 was 4.97 Million SEK , down -50.4% from previous year.
  • BioArctic AB (publ)'s latest quarterly total debt in 2024 Q2 was 59.7 Million SEK , up 1282.06% from previous quarter.
  • BioArctic AB (publ) reported annual total debt of 10.03 Million SEK in 2022, down -36.77% from previous year.
  • BioArctic AB (publ) reported annual total debt of 15.87 Million SEK in 2021, down -23.55% from previous year.
  • BioArctic AB (publ) reported quarterly total debt of 4.32 Million SEK for 2024 Q1, down -13.24% from previous quarter.
  • BioArctic AB (publ) reported quarterly total debt of 7.92 Million SEK for 2023 Q1, down -21.11% from previous quarter.

Annual Total Debt Chart of BioArctic AB (publ) (2023 - 2015)

Historical Annual Total Debt of BioArctic AB (publ) (2023 - 2015)

Year Total Debt Total Debt Growth
2023 4.97 Million SEK -50.4%
2022 10.03 Million SEK -36.77%
2021 15.87 Million SEK -23.55%
2020 20.76 Million SEK -24.11%
2019 27.36 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%

Peer Total Debt Comparison of BioArctic AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 69.069%
Ziccum AB (publ) 857 Thousand SEK -480.98%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 79.668%
Genovis AB (publ.) 79.32 Million SEK 93.723%
Intervacc AB (publ) 181 Thousand SEK -2650.829%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 75.843%
Active Biotech AB (publ) 3 Million SEK -65.967%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 91.743%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 0.42%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 93.027%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 36.395%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -1074.292%
Egetis Therapeutics AB (publ) 108.6 Million SEK 95.415%
Karolinska Development AB (publ) 3.07 Million SEK -62.182%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK -92.984%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -397.9%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.491%
Camurus AB (publ) 24.5 Million SEK 79.683%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 81.938%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.426%
Cyxone AB (publ) 858 Thousand SEK -480.303%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK -190.999%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 86.473%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -647.598%
SynAct Pharma AB 637 Thousand SEK -681.633%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -485.765%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -182.737%
BioInvent International AB (publ) 23.24 Million SEK 78.579%
Alzinova AB (publ) 800 Thousand SEK -522.375%
Oncopeptides AB (publ) 106.48 Million SEK 95.324%
Pila Pharma AB (publ) 773.08 Thousand SEK -544.047%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 94.513%
Diamyd Medical AB (publ) 30.67 Million SEK 83.767%
Xbrane Biopharma AB (publ) 231.47 Million SEK 97.849%
Ascelia Pharma AB (publ) 1.06 Million SEK -369.274%
Diagonal Bio AB (publ) - SEK -Infinity%